These 6 portfolio names pledged big U.S. investments since Trump took office again

These 6 portfolio names pledged big U.S. investments since Trump took office again

Many of the biggest U.S. companies have pledged to invest trillions of dollars in the United States since President Donald Trump started his second term — including six names in our portfolio. These moves are aimed at aligning companies with the president’s vision for a new global trade order designed to bring manufacturing jobs back … Read more

Trump signs order to boost domestic drug manufacturing as pharma tariffs loom

Trump signs order to boost domestic drug manufacturing as pharma tariffs loom

U.S. President Donald Trump speaks before signing executive orders in the Oval Office at the White House, in Washington, D.C., U.S., May 5, 2025. Leah Millis | Reuters President Donald Trump on Monday signed an executive order to incentivize prescription drug manufacturing in the U.S., streamlining the path for pharmaceutical companies to build new production … Read more

Eli Lilly CEO says company can help ‘respond’ to national security concerns around essential drugs as tariffs loom

Eli Lilly CEO says company can help ‘respond’ to national security concerns around essential drugs as tariffs loom

CEO of Eli Lilly and Company David Ricks speaks at the Economic Club of New York on March 12, 2024 in New York City. Spencer Platt | Getty Images Eli Lilly CEO Dave Ricks on Thursday said the drugmaker can help “respond” to national security concerns around cheaper essential medicines as pharmaceutical-specific tariffs loom.  The … Read more

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal

Eli Lilly on Thursday reported first-quarter revenue and earnings that topped estimates as demand for its weight loss and diabetes drugs soared, but lowered its full-year profit guidance due to charges related to a recent cancer treatment deal. The pharmaceutical giant now expects its adjusted fiscal 2025 earnings to come in between $20.78 and $22.28 … Read more

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom

Jgi/jamie Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Tariff threats — and efforts to get into President Donald Trump’s good graces — are fueling a new wave … Read more

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York City, U.S., May 22, 2024.  Andrew Kelly | Reuters Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and … Read more

Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall

Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall

The Pfizer logo is seen outside the pharmaceutical company’s manufacturing plant, in Newbridge, Ireland February 10, 2025.  Clodagh Kilcoyne | Reuters Pfizer on Tuesday expanded its cost-cutting efforts and reported first-quarter profit that topped estimates, even as the company’s sales fell, largely due to dwindling revenue for its antiviral Covid pill Paxlovid. The company previously … Read more

Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic

Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic

Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025.  Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk scored a huge legal victory that … Read more

Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

FILE PHOTO: The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday beat first-quarter estimates and hiked its revenue and profit guidance for the year, as the drugmaker cuts costs. The company now expects 2025 … Read more

Merck lowers profit outlook, partly due to $200 million expected tariff hit

Merck lowers profit outlook, partly due to 0 million expected tariff hit

Nurphoto | Nurphoto | Getty Images Merck on Thursday lowered its full-year profit guidance, citing $200 million in estimated costs for tariffs and a charge tied to a recent deal. The company now expects its 2025 adjusted earnings to come in between $8.82 and $8.97, down slightly from a previous outlook of 8.88 to $9.03 … Read more